Cargando…

High prostate‐specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI‐RADS score 4 or 5 confers a high probability of significant prostate cancer

Detalles Bibliográficos
Autores principales:	Ptasznik, Gideon, Papa, Nathan, Kelly, Brian D., Thompson, James, Stricker, Phillip, Roberts, Matthew J., Hofman, Michael S., Buteau, James, Murphy, Declan G., Emmett, Louise, Moon, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Urological Society of Australia and New Zealand
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790460/ https://www.ncbi.nlm.nih.gov/pubmed/35362659 http://dx.doi.org/10.1111/bju.15736

Ejemplares similares

Event‐free survival after radical prostatectomy according to prostate‐specific membrane antigen‐positron emission tomography and European Association of Urology biochemical recurrence risk groups
por: Roberts, Matthew J., et al.
Publicado: (2022)

Large variation in conservative management of low‐risk prostate cancer in Australia and New Zealand
por: Ong, Wee Loon, et al.
Publicado: (2022)

Prostate cancer survivorship care: if not now, when?
por: Dunn, Jeffrey, et al.
Publicado: (2021)

Prostate cancer survivorship essentials framework: guidelines for practitioners
por: Dunn, Jeff, et al.
Publicado: (2020)

Pathological predictors of (18)F‐DCFPyL prostate‐specific membrane antigen‐positive recurrence after radical prostatectomy
por: Perry, Elisa, et al.
Publicado: (2022)

The safety of surgical mesh: what is online video content teaching our patients?
por: Parkin, Cameron James, et al.
Publicado: (2022)

Oncological and urinary outcomes following low‐dose‐rate brachytherapy with a median follow‐up of 11.8 years
por: Yaxley, William John, et al.
Publicado: (2022)

Long‐term outcomes of polyacrylamide hydrogel treatment in women with stress urinary incontinence
por: Hoe, Venetia, et al.
Publicado: (2022)

Guideline of guidelines: management of recurrent urinary tract infections in women
por: Kwok, Michael, et al.
Publicado: (2022)

Prostate cancer mortality outcomes and patterns of primary treatment for Aboriginal men in New South Wales, Australia
por: Rodger, Jennifer C., et al.
Publicado: (2015)

A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy
por: Kelly, Brian D., et al.
Publicado: (2023)

Distribution of prostate cancer recurrences on gallium‐68 prostate‐specific membrane antigen ((68)Ga‐PSMA) positron‐emission/computed tomography after radical prostatectomy with pathological node‐positive extended lymph node dissection
por: Huits, Thijs H., et al.
Publicado: (2020)

Prostate-specific membrane antigen positron emission tomography compared to multiparametric MRI for prostate cancer diagnosis: a protocol for a systematic review and meta-analysis
por: Zhao, Yi, et al.
Publicado: (2021)

PEDAL protocol: a prospective single-arm paired comparison of multiparametric MRI and 18F-DCPFyl PSMA PET/CT to diagnose prostate cancer
por: Tran, Vy, et al.
Publicado: (2022)

Prostatic hyperplasia is highly associated with nocturia and excessive sleepiness: a cross-sectional study
por: Chartier-Kastler, Emmanuel, et al.
Publicado: (2012)

COmparing Urolift and Standard Transurethral resection of prostate Ahead of Radiotherapy in men with urinary symptoms secondary to prostate enlargement in Southwest London and North Cumbria (CO-STAR): a study protocol for a randomised feasibility study
por: Wong, Kathie, et al.
Publicado: (2023)

Determinants of outcome following PSMA-based radioligand therapy and mechanisms of resistance in patients with metastatic castration-resistant prostate cancer
por: Kostos, Louise, et al.
Publicado: (2023)

Focal Cryoablation of the Prostate: Primary Treatment in 163 Patients With Localized Prostate Cancer
por: Khan, Anwar, et al.
Publicado: (2023)

Protocol for SNOTOB study: radical prostatectomy without prostate biopsy following (18)F-PSMA-1007 PET/CT based on a diagnostic model: a single-centre, single-arm, open-label study
por: Wang, Changming, et al.
Publicado: (2023)

Clinical and Histopathological Characteristics of Prostate Cancer Patients Taken to Palliative Transurethral Prostate Resection
por: Rojas-Manrique, Juan P, et al.
Publicado: (2019)

Disseminated Intravascular Coagulation With Excessive Fibrinolysis Following Diagnostic Prostatic Biopsy for Prostate Cancer
por: Ghallab, Muhammad, et al.
Publicado: (2022)

A Report on the Clinical Outcome after High-Dose Rate (HDR) Brachytherapy as Monotherapy in Early Prostate Cancer
por: Potharaju, Mahadev, et al.
Publicado: (2015)

Contemporary Management of Chronic Prostatitis
por: Khattak, Ahmed S, et al.
Publicado: (2021)

Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET
por: Leung, Kevin H., et al.
Publicado: (2022)

Aquablation versus holmium laser enucleation of the prostate in the treatment of benign prostatic hyperplasia in medium-to-large-sized prostates (ATHLETE): protocol of a prospective randomised trial
por: Müllhaupt, Gautier, et al.
Publicado: (2021)

Correlation of Postoperative Outcomes According to the Amount of Prostatic Tissue Removed in Patients Undergoing Transurethral Resection of the Prostate
por: Turgut, Ömer, et al.
Publicado: (2023)

Hemophagocytic Lymphohistiocytosis Secondary to Prostatic Adenocarcinoma
por: Rajapakse, Pramuditha, et al.
Publicado: (2021)

Prostate MRI versus PSA screening for prostate cancer detection (the MVP Study): a randomised clinical trial
por: Nam, Robert, et al.
Publicado: (2022)

The Predictive Value of Prostate-Specific Antigen Density: A Retrospective Analysis of Likert 3 Multiparametric MRI of the Prostate
por: Feyisetan, Oladapo, et al.
Publicado: (2023)

PCASTt/SPCG-17—a randomised trial of active surveillance in prostate cancer: rationale and design
por: Ahlberg, Mats Steinholtz, et al.
Publicado: (2019)

Leptomeningeal Metastases in Hormone Refractory Prostate Cancer
por: Ng, Jessica Y, et al.
Publicado: (2018)

Prostate Cancer Support Groups: The Unadvertised Camaraderie
por: Santarelli, Shana, et al.
Publicado: (2021)

Metastatic Prostate Adenocarcinoma: A Rare Presentation
por: Rodriguez, Pierre, et al.
Publicado: (2022)

Decision analytic cost-effectiveness model to compare prostate cryotherapy to androgen deprivation therapy for treatment of radiation recurrent prostate cancer
por: Boyd, Kathleen A, et al.
Publicado: (2015)

A Comparative Study: Has MRI-guided Fusion Prostate Biopsy Changed the Prostate-specific Antigen Gray-zone Range?
por: Sönmez, Gökhan, et al.
Publicado: (2019)

Monopolar Transurethral Resection of Prostate for Benign Prostatic Hyperplasia in Patients With and Without Preoperative Urinary Catheterization: A Prospective Comparative Study
por: Adhikari, Baikuntha, et al.
Publicado: (2021)

Diagnostic and prognostic factors in patients with prostate cancer: a systematic review
por: Beyer, Katharina, et al.
Publicado: (2022)

Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol
por: Beyer, Katharina, et al.
Publicado: (2021)

Guiding management of therapy in prostate cancer: time to switch from conventional imaging to PSMA PET?
por: Alipour, Ramin, et al.
Publicado: (2019)

Primary Non-Hodgkins Lymphoma of the prostate presenting as haematuria
por: Rizvi, Fahad A, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_06s0f67tvparalfkd4gephni8h